Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

Multiple sclerosis (MS) is a common neurological disease with increasing incidence and prevalence. Onset of disease is most frequently in young adulthood when productivity is usually highest; it is of chronic nature and, in the majority of patients, it will result in accumulation of disability. Due...

Descripción completa

Detalles Bibliográficos
Autores principales: Castrop, Florian, Haslinger, Bernhard, Hemmer, Bernhard, Buck, Dorothea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783501/
https://www.ncbi.nlm.nih.gov/pubmed/24072971
http://dx.doi.org/10.2147/NDT.S33949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783501/
https://www.ncbi.nlm.nih.gov/pubmed/24072971
http://dx.doi.org/10.2147/NDT.S33949

Ejemplares similares